Case Challenge

Management of Severe HBV Infection in the Pre- and Post-Transplant Setting

Source: Diagnosis, Treatment, and Chronic Care Options for Hepatitis B

Management of Severe HBV Infection in the Pre- and Post-Transplant Setting


CME Program Director: Patrick J. Lynch, MD

Program Director: Eugene R. Schiff, MD, MACP, FRCP, MACG

Faculty:

  • Raymond T. Chung, MD

CME CREDIT INFORMATION

Release Date: 07/18/05

Expiration Date: 07/17/06


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review data on the use of immunoprophylaxis to prevent HBV recurrences after liver transplantation

  • Outline the potential role of tenofovir in the treatment of chronic HBV infection

  • Describe the potential clinical benefits and risks associated with the use of nucleoside analogues in patients with decompensated HBV liver disease


Test your ability to provide optimal clinical management for decompensated patient with chronic hepatitis B.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.